Journal Mobile Options
Table of Contents
Vol. 57, Suppl. 2, 2002
Issue release date: 2002
Horm Res 2002;57(suppl 2):71–78

IMAGe Association: Additional Clinical Features and Evidence for Recessive Autosomal Inheritance

Lienhardt A. · Mas J.-C. · Kalifa G. · Chaussain J.-L. · Tauber M.
aService d’Endocrinologie Pédiatrique, Hôpital Saint Vincent de Paul, Paris; bEndocrinologie, Hôpital des Enfants, Centre Hospitalier Universitaire, Toulouse; cService de Radiologie Pédiatrique, Hôpital Saint Vincent de Paul, Paris, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Congenital adrenal hypoplasia (CAH) normally occurs in the neonatal period, with patients presenting with more or less severe salt-wasting syndrome. X-linked CAH has been associated with mutations in the DAX-1 gene, and boys have also been shown to have hypogonadotrophic hypogonadism. Recently, in three unrelated boys, CAH was associated with intrauterine growth retardation (IUGR), metaphyseal dysplasia and genital abnormalities, defining a new association called IMAGe. We now report four additional patients with this association, including the first living female. The four patients belong to two unrelated families (one brother and one sister from each family). These patients have the main clinical characteristics of IMAGe association: IUGR, facial dysmorphy (frontal bossing, broad nasal bridge, low-set ears), short limbs due to metaphyseal dysplasia, and adrenal insufficiency. As these patients are older than the initial three patients, we can also describe additional features: short adult height, normal puberty in boys as well as in the living girl. The boys have hypospadias associated with micropenis. The living girl came to clinical attention at the age of 5 years as a result of a familial survey, and careful questioning revealed that she had been suffering from mild adrenal insufficiency since early childhood. At least one boy has congenital hypotonia due to muscular dystrophy. In conclusion, these four new cases display familial transmission, strongly suggesting Mendelian autosomal recessive inheritance. Adrenal insufficiency may be mild. Hypotonia, described in all the patients, might be related to paucisymptomatic muscular dystrophy, as this condition is clearly heterogeneous varying with regard to severity, associated manifestations and outcome. If this symptom is part of the syndrome, which we cannot assume, it could help to localize the candidate gene.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Uttley WS: Familial congenital adrenal hypoplasia. Arch Dis Child 1968;43:724–730.

    External Resources

  2. Kelch RP, Virdis R, Rapaport R, Greig F, Levine LS, New MI: Congenital adrenal hypoplasia. Paediatr Adolesc Endocr 1984;13:156–161.
  3. Weiss L, Mellinger RC: Congenital adrenal hypoplasia – an X-linked disease. J Med Genet 1970;7:27–32.

    External Resources

  4. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ER, Meitinger T, Monaco A, Sassone-Corsi P, Camerino G: An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635–641.
  5. Peter M, Viemann M, Partsch CJ, Sippell WG: Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J Clin Endocrinol Metab 1998;83:2666–2674.
  6. Bartley JA, Miller DK, Hayford JT, McCabe ER: Concordance of X-linked glycerol kinase deficiency with X-linked congenital adrenal hypoplasia. Lancet 1982;2:733–736.

    External Resources

  7. Francke U, Harper JF, Darras BT, Cowan JM, McCabe ERB, Kohlschutter A, Seltzer WK, Saito F, Goto J, Harper JP, Wise JE: Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet 1987;40:212–227.
  8. Vilain E, Le Merrer M, Lecointre C, Desangles F, Kay MA, Maroteaux P, McCabe ER: IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J Clin Endocrinol Metab 1999;84:4335–4340.
  9. Usher R, McLean F: Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969;74:901–910.
  10. Huebner A, Elias LL, Clark AJ: ACTH resistance syndromes. J Pediatr Endocrinol Metab 1999;12(suppl 1):277–293.
  11. Luo X, Ikeda Y, Lala D, Rice D, Wong M, Parker KL: Steroidogenic factor 1 (SF-1) is essential for endocrine development and function. J Steroid Biochem Mol Biol 1999;69:13–18.

    External Resources

  12. Achermann JC, Ito M, Hindermarsh PC, Jameson JL: A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999;22:125–126.
  13. Miller WL, Strauss JF III: Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. J Steroid Biochem Mol Biol 1999;69:131–141.

    External Resources

  14. Jüppner H, Schippani E: The parathyroid hormone/parathyroid hormone-related peptide receptor in Jansen’s metaphyseal chondrodysplasia. Curr Opin Endocrinol Diabetes 1997;4:433–442.
  15. Lachman RS, Rimoin DL, Spranger J: Metaphyseal chondrodysplasia, Schmid type. Clinical and radiographic delineation with a review of the literature. Pediatr Radiol 1988;18:93–102.

    External Resources

  16. Roland EH: Muscular dystrophy. Pediatr Rev 2000;21:233–237.

    External Resources

  17. Aicardi J: Primary muscle disease; in Diseases of the Nervous System in Childhood, ed 2. London, Cambridge University Press: MacKeith Press, 1998, pp 750–790.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50